Hydase

Hydase is a brand name of hyaluronidase, approved by the FDA in the following formulation(s):

HYDASE (hyaluronidase - injectable; injection)

• 
  Manufacturer: AKORN INC
  
  Approval date: October 25, 2005
  
  Strength(s): 150 UNITS/ML ^[RLD]

Has a generic version of Hydase been approved?

No. There is currently no therapeutically equivalent version of Hydase available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Hydase. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Hydase.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • October 25, 2010 - NEW CHEMICAL ENTITY
  
  

See also...

• Hydase injectable Consumer Information (Cerner Multum)
• Hydase Advanced Consumer Information (Micromedex)
• Hyaluronidase Consumer Information (Wolters Kluwer)
• Hyaluronidase injectable Consumer Information (Cerner Multum)
• Hyaluronidase Subcutaneous, Injection Advanced Consumer Information (Micromedex)